I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 32% ± 15% | |
| oligodendrocyte | 5 studies | 26% ± 6% | |
| type I pneumocyte | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 32% ± 15% | |
| oligodendrocyte | 5 studies | 26% ± 6% | |
| type I pneumocyte | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 30% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 9557.60 | 2625 / 2642 | 100% | 53.48 | 703 / 705 |
| prostate | 100% | 10637.80 | 245 / 245 | 99% | 26.38 | 495 / 502 |
| liver | 100% | 11370.11 | 226 / 226 | 98% | 45.64 | 397 / 406 |
| ovary | 98% | 7510.74 | 177 / 180 | 99% | 61.69 | 424 / 430 |
| skin | 100% | 6681.17 | 1802 / 1809 | 97% | 34.79 | 459 / 472 |
| kidney | 100% | 9494.46 | 89 / 89 | 96% | 29.08 | 868 / 901 |
| breast | 100% | 10136.65 | 459 / 459 | 95% | 21.79 | 1057 / 1118 |
| esophagus | 100% | 9961.24 | 1439 / 1445 | 93% | 17.41 | 171 / 183 |
| thymus | 100% | 8565.08 | 653 / 653 | 93% | 19.87 | 561 / 605 |
| stomach | 100% | 6091.55 | 358 / 359 | 90% | 14.52 | 257 / 286 |
| lung | 99% | 7808.32 | 575 / 578 | 89% | 17.83 | 1028 / 1155 |
| uterus | 100% | 8729.28 | 170 / 170 | 88% | 16.20 | 402 / 459 |
| intestine | 100% | 9270.02 | 965 / 966 | 87% | 13.37 | 461 / 527 |
| pancreas | 95% | 3636.79 | 311 / 328 | 91% | 16.95 | 162 / 178 |
| bladder | 100% | 7310.24 | 21 / 21 | 84% | 13.98 | 421 / 504 |
| adrenal gland | 98% | 4134.44 | 253 / 258 | 65% | 8.07 | 150 / 230 |
| adipose | 100% | 8189.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.69 | 1 / 1 |
| blood vessel | 100% | 9932.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 27.24 | 79 / 80 |
| spleen | 98% | 4252.47 | 237 / 241 | 0% | 0 | 0 / 0 |
| heart | 95% | 3910.06 | 818 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 9.90 | 36 / 45 |
| muscle | 52% | 1361.52 | 419 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 2.43 | 8 / 29 |
| peripheral blood | 3% | 65.94 | 30 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030182 | Biological process | neuron differentiation |
| GO_0016242 | Biological process | negative regulation of macroautophagy |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | NRBP2 |
| Protein name | Nuclear receptor binding protein 2 Nuclear receptor-binding protein 2 (Transformation-related gene 16 protein) (TRG-16) |
| Synonyms | TRG16 PP9320 |
| Description | FUNCTION: May regulate apoptosis of neural progenitor cells during their differentiation. . |
| Accessions | ENST00000530347.1 E9PR11 ENST00000530123.1 H0YCB1 Q9NSY0 ENST00000442628.7 [Q9NSY0-3] |
